Mediwound launches clinical development program for treatment of non-melanoma skin cancer

Phase i/ii clinical study in basal cell carcinoma scheduled to begin second quarter 2021, with data expected by the end of 2021
MDWD Ratings Summary
MDWD Quant Ranking